Volpe M - Search Results

1

Restoring the dysfunctional endothelium.

Osto E, Coppolino G, Volpe M, Cosentino F. Osto E, et al. Among authors: volpe m. Curr Pharm Des. 2007;13(10):1053-68. doi: 10.2174/138161207780487566. Curr Pharm Des. 2007. PMID: 17430168 Review.

2

Impaired vasorelaxant responses to natriuretic peptides in the stroke-prone phenotype of spontaneously hypertensive rats.

Russo R, Vecchione C, Cosentino F, Natale A, Mele AF, Muscolo M, Savoia C, Ganten D, Rubattu S, Volpe M. Russo R, et al. Among authors: volpe m. J Hypertens. 1998 Feb;16(2):151-6. doi: 10.1097/00004872-199816020-00004. J Hypertens. 1998. PMID: 9535141

3

Abnormalities of endothelial function in the pathogenesis of stroke: the importance of endothelin.

Volpe M, Cosentino F. Volpe M, et al. J Cardiovasc Pharmacol. 2000;35(4 Suppl 2):S45-48. doi: 10.1097/00005344-200000002-00011. J Cardiovasc Pharmacol. 2000. PMID: 10976781 Review.

4

Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice.

Cosentino F, Barker JE, Brand MP, Heales SJ, Werner ER, Tippins JR, West N, Channon KM, Volpe M, Lüscher TF. Cosentino F, et al. Among authors: volpe m. Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):496-502. doi: 10.1161/01.atv.21.4.496. Arterioscler Thromb Vasc Biol. 2001. PMID: 11304463

5

Endothelial dysfunction and stroke.

Cosentino F, Rubattu S, Savoia C, Venturelli V, Pagannonne E, Volpe M. Cosentino F, et al. Among authors: volpe m. J Cardiovasc Pharmacol. 2001 Nov;38 Suppl 2:S75-8. doi: 10.1097/00005344-200111002-00018. J Cardiovasc Pharmacol. 2001. PMID: 11811384 Review.

6

Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade.

Cosentino F, Bonetti S, Rehorik R, Eto M, Werner-Felmayer G, Volpe M, Lüscher TF. Cosentino F, et al. Among authors: volpe m. J Hypertens. 2002 Mar;20(3):421-8. doi: 10.1097/00004872-200203000-00017. J Hypertens. 2002. PMID: 11875309

7

Antihypertensive effect and end-organ protection of flavonoids: some insights, more questions.

Cosentino F, Volpe M. Cosentino F, et al. Among authors: volpe m. J Hypertens. 2002 Sep;20(9):1721-4. doi: 10.1097/00004872-200209000-00013. J Hypertens. 2002. PMID: 12195110 Review. No abstract available.

8

High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species.

Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Delli Gatti C, Joch H, Volpe M, Lüscher TF. Cosentino F, et al. Among authors: volpe m. Circulation. 2003 Feb 25;107(7):1017-23. doi: 10.1161/01.cir.0000051367.92927.07. Circulation. 2003. PMID: 12600916

9

Do COX-2 inhibitors really prevent hypertension and proteinuria? Another brick in the wall for the COX-2 inhibition and cardiovascular disease controversy.

Cosentino F, Francia P, Volpe M. Cosentino F, et al. Among authors: volpe m. J Hypertens. 2003 Mar;21(3):501-3. doi: 10.1097/00004872-200303000-00013. J Hypertens. 2003. PMID: 12640241 No abstract available.

10

Is it time to measure microalbuminuria in hypertension?

Volpe M, Cosentino F, Ruilope LM. Volpe M, et al. J Hypertens. 2003 Jul;21(7):1213-20. doi: 10.1097/00004872-200307000-00001. J Hypertens. 2003. PMID: 12817160 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,380 results

Search Page

Filters